Healthcare major Narayana Hrudayalaya reported a 30% year-on-year rise in Q2 net profit to ₹258 crore, triggering a 15% surge in shares. The company’s strong performance came on the back of steady revenue growth, better operational metrics, and rising demand for clinical specialties.
The management highlighted that both domestic and overseas units performed well during the quarter, supported by strategic capacity additions and strengthened clinical programmes. With profitability improving across segments, investors reacted positively, pushing the stock to multi-month highs.
Analysts suggest that sustained growth momentum and planned expansions could drive further upside.
